This study demonstrates antimicrobial activity of postbiotic cell-free supernatant against multiple pathogens, suggesting it as a viable infection management alternative.
This study examines the antimicrobial potential of the cell-free supernatant of a Lactobacillus isolate. The isolate was identified accurately by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Antimicrobial potential against four common pathogenic bacteria, namely Escherichia coli, Enterococcus faecalis, Salmonella enterica, and Streptococcus bovis, was determined by agar well diffusion assay. The results demonstrated concentration-dependent increases in inhibition zones for all tested pathogens; the postbiotic showed significant antimicrobial potential similar to reference antibiotics. This study demonstrates the potential of probiotic cell-free supernatant as a bioactive postbiotic agent that can inhibit pathogenic bacteria, thus providing alternative infection control. The results also suggest the potential of the postbiotic in being developed as a bioactive antimicrobial agent for infection management.
No takes yet. Share an insight, caveat, or question.
R Mahenthiran (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: